SSY Group Future Growth
Future criteria checks 5/6
SSY Group is forecast to grow earnings and revenue by 20.9% and 21% per annum respectively while EPS is expected to grow by 21.1% per annum.
Key information
20.9%
Earnings growth rate
21.1%
EPS growth rate
Pharmaceuticals earnings growth | 23.9% |
Revenue growth rate | 21.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 24 Jul 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 12,473 | 2,161 | N/A | 1,801 | 2 |
12/31/2024 | 9,831 | 1,759 | 1,017 | 1,333 | 4 |
12/31/2023 | 7,945 | 1,431 | 578 | 945 | 4 |
12/31/2022 | 6,434 | 1,123 | 316 | 734 | N/A |
9/30/2022 | 6,376 | 1,101 | 318 | 752 | N/A |
6/30/2022 | 6,318 | 1,080 | 321 | 769 | N/A |
3/31/2022 | 5,838 | 933 | 314 | 733 | N/A |
12/31/2021 | 5,357 | 786 | 307 | 696 | N/A |
9/30/2021 | 5,139 | 713 | 205 | 605 | N/A |
6/30/2021 | 4,921 | 641 | 102 | 514 | N/A |
3/31/2021 | 4,591 | 626 | 143 | 509 | N/A |
12/31/2020 | 4,261 | 612 | 183 | 505 | N/A |
9/30/2020 | 4,177 | 723 | 140 | 558 | N/A |
6/30/2020 | 4,093 | 835 | 97 | 611 | N/A |
3/31/2020 | 4,364 | 985 | -47 | 628 | N/A |
12/31/2019 | 4,636 | 1,136 | -190 | 646 | N/A |
9/30/2019 | 4,525 | 1,075 | -164 | 629 | N/A |
6/30/2019 | 4,414 | 1,014 | -138 | 612 | N/A |
3/31/2019 | 4,297 | 963 | 126 | 791 | N/A |
12/31/2018 | 4,181 | 912 | 390 | 970 | N/A |
9/30/2018 | 4,012 | 867 | 385 | 906 | N/A |
6/30/2018 | 3,844 | 822 | 380 | 843 | N/A |
3/31/2018 | 3,460 | 743 | 279 | 698 | N/A |
12/31/2017 | 3,076 | 665 | 179 | 552 | N/A |
9/30/2017 | 2,827 | 616 | 283 | 676 | N/A |
6/30/2017 | 2,577 | 567 | 387 | 799 | N/A |
3/31/2017 | 2,469 | 528 | 375 | 743 | N/A |
12/31/2016 | 2,361 | 490 | 364 | 686 | N/A |
9/30/2016 | 2,315 | 426 | N/A | 579 | N/A |
6/30/2016 | 2,270 | 363 | N/A | 472 | N/A |
3/31/2016 | 2,246 | 383 | N/A | 517 | N/A |
12/31/2015 | 2,222 | 403 | N/A | 563 | N/A |
9/30/2015 | 2,189 | 443 | N/A | 326 | N/A |
6/30/2015 | 2,156 | 482 | N/A | 89 | N/A |
3/31/2015 | 2,124 | 487 | N/A | 198 | N/A |
12/31/2014 | 2,091 | 492 | N/A | 308 | N/A |
6/30/2014 | 1,309 | 402 | N/A | 613 | N/A |
3/31/2014 | 1,516 | 386 | N/A | 605 | N/A |
12/31/2013 | 1,723 | 369 | N/A | 598 | N/A |
9/30/2013 | 2,681 | 386 | N/A | 594 | N/A |
6/30/2013 | 2,618 | 359 | N/A | 590 | N/A |
3/31/2013 | 2,524 | 320 | N/A | 416 | N/A |
12/31/2012 | 2,431 | 281 | N/A | 242 | N/A |
9/30/2012 | 2,360 | 127 | N/A | 184 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LJUI.F's forecast earnings growth (20.9% per year) is above the savings rate (2.1%).
Earnings vs Market: LJUI.F's earnings (20.9% per year) are forecast to grow faster than the US market (14.9% per year).
High Growth Earnings: LJUI.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LJUI.F's revenue (21% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: LJUI.F's revenue (21% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LJUI.F's Return on Equity is forecast to be high in 3 years time